The management of minimal extent mycosis fungoides.
D003131:Combined Modality Therapy; D006801:Humans; D009182:Mycosis Fungoides / Q000473:pathology / Q000628:therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011701:PUVA Therapy; D011379:Prognosis; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
D009588:Nitrogen Mustard Compounds